BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 11561768)

  • 1. Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples.
    Konecny G; Untch M; Slamon D; Beryt M; Kahlert S; Felber M; Langer E; Lude S; Hepp H; Pegram M
    Breast Cancer Res Treat; 2001 Jun; 67(3):223-33. PubMed ID: 11561768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.
    Pegram MD; Konecny GE; O'Callaghan C; Beryt M; Pietras R; Slamon DJ
    J Natl Cancer Inst; 2004 May; 96(10):739-49. PubMed ID: 15150302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
    Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
    Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling.
    Oliveras-Ferraros C; Vazquez-Martin A; Colomer R; De Llorens R; Brunet J; Menendez JA
    Int J Oncol; 2008 Jan; 32(1):113-20. PubMed ID: 18097549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines.
    Budman DR; Calabro A
    Breast Cancer Res Treat; 2002 Jul; 74(1):41-6. PubMed ID: 12150451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma.
    Voigt W; Kegel T; Weiss M; Mueller T; Simon H; Schmoll HJ
    J Cancer Res Clin Oncol; 2005 Sep; 131(9):585-90. PubMed ID: 16021466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schedule-dependent interactions between vinorelbine and paclitaxel in human carcinoma cell lines in vitro.
    Kano Y; Akutsu M; Suzuki K; Ando J; Tsunoda S
    Breast Cancer Res Treat; 1999 Jul; 56(1):79-90. PubMed ID: 10517345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents.
    Budman DR; Calabro A
    Oncology; 2006; 70(2):147-53. PubMed ID: 16645328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of synergism or antagonism with combinations of new cytotoxic agents.
    Budman DR; Calabro A; Kreis W
    Anticancer Drugs; 1998 Sep; 9(8):697-702. PubMed ID: 9823428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer.
    Tang H; Chen J; Wang L; Li Q; Yang Y; Lv Z; Bao H; Li Y; Luan X; Li Y; Ren Z; Zhou X; Cong D; Liu Z; Jia J; Chen H; Zhao W; Meng Q; Sun F; Pei J
    Int J Pharm; 2020 Jan; 573():118806. PubMed ID: 31678519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Three-Drug Combination Pharmacodynamic Interactions in Pancreatic Cancer Cells.
    Molins EAG; Jusko WJ
    AAPS J; 2018 Jun; 20(5):80. PubMed ID: 29951754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism of cytotoxic effects of vinorelbine and paclitaxel in vitro.
    Budman DR; Calabro A; Wang LG; Liu XM; Stiel L; Adams LM; Kreis W
    Cancer Invest; 2000; 18(8):695-701. PubMed ID: 11107439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinations of paclitaxel and vinblastine and their effects on tubulin polymerization and cellular cytotoxicity: characterization of a synergistic schedule.
    Giannakakou P; Villalba L; Li H; Poruchynsky M; Fojo T
    Int J Cancer; 1998 Jan; 75(1):57-63. PubMed ID: 9426691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines.
    Edelman MJ; Quam H; Mullins B
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):141-4. PubMed ID: 11561780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients.
    Comella P; Frasci G; Carnicelli P; Massidda B; Buzzi F; Filippelli G; Maiorino L; Guida M; Panza N; Mancarella S; Cioffi R
    Br J Cancer; 2004 Aug; 91(3):489-97. PubMed ID: 15266334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro chemoresponse assay based on the intrinsic subtypes in breast cancer.
    Gwe Ahn S; Ah Lee S; Woo Lee H; Min Lee H; Jeong J
    Jpn J Clin Oncol; 2014 Jul; 44(7):624-31. PubMed ID: 24803548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells.
    Menendez JA; Colomer R; Lupu R
    Oncol Rep; 2004 Aug; 12(2):411-22. PubMed ID: 15254710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction.
    Logan KA; Nesbitt H; Callan B; Gao J; McKaig T; Taylor M; Love M; McHale AP; Callan JF
    Eur J Pharm Biopharm; 2021 Aug; 165():374-382. PubMed ID: 34038797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination paclitaxel and vinorelbine therapy: in vitro cytotoxic interactions and dose-escalation study in breast cancer patients previously exposed to anthracyclines.
    Culine S; Roch I; Pinguet F; Romieu G; Bressolle F
    Int J Oncol; 1999 May; 14(5):999-1006. PubMed ID: 10200354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New combinations with Herceptin in metastatic breast cancer.
    Winer EP; Burstein HJ
    Oncology; 2001; 61 Suppl 2():50-7. PubMed ID: 11694788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.